Omeros Corporation (OMER) Estados Financieros e Histórico

Omeros Corporation (OMER) — Precio $17.34 HealthcareBiotechnology — NASDAQ

Últimos resultados publicados:

Estados financieros detallados de Omeros Corporation (OMER): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.

Resumen del Análisis

Márgenes de los últimos 12 meses: margen bruto 95.8%, margen operativo -189.5%, margen neto 324.9%.

Al precio actual de $17.34, OMER cotiza a un P/E de 8.04 y un ROE del -109.40%. La capitalización bursátil es de $1.3B.

Cuenta de Resultados (10 años)

Año2016201720182019202020212022202320242025
Ingresos$41.6M$64.8M$29.9M$111.8M000000
Coste de Ventas$1.4M$1.1M$512000$2.7M$1.6M$1.4M0000
Beneficio Bruto$40.2M$63.7M$29.4M$109.2M-$1.6M-$1.4M0000
I+D$50.7M$55.6M$89.9M$109.7M$107.6M$118.8M$112.7M$114.9M$119.5M$81.3M
Generales y Administrativos$43.8M$52.0M$51.7M$62.8M$47.7M$53.5M$50.7M$49.7M$49.7M$41.5M
Gastos Operativos$94.5M$107.6M$141.6M$172.5M$155.3M$172.2M$163.4M$164.5M$169.3M$122.8M
Beneficio Operativo-$54.3M-$43.9M-$112.2M-$63.4M-$156.9M-$173.6M-$163.4M-$164.5M-$169.3M-$122.8M
EBITDA-$58.6M-$41.9M-$122.5M-$60.0M-$168.0M-$170.5M-$158.4M-$143.2M-$157.0M-$1.8M
Gastos por Intereses$7.8M$11.0M$16.3M$22.7M$26.8M$19.7M$22.7M$30.8M$24.7M0
Beneficio Antes de Impuestos-$66.7M-$53.5M-$139.7M-$84.5M-$196.4M-$191.5M-$182.0M-$174.9M-$182.6M-$2.8M
Impuestos00-$12.9M0-$23.3M0000$2.0M
Beneficio Neto-$66.7M-$53.5M-$126.8M-$84.5M-$138.1M-$111.4M$47.4M-$117.8M-$156.8M-$3.4M
BPA$-1.65$-1.17$-2.61$-2.16$-2.41$-1.79$0.46$-1.88$-2.70$-0.05
BPA Diluido$-1.65$-1.17$-2.61$-2.16$-2.41$-1.79$0.46$-1.88$-2.70$-0.05
Acciones en Circulación (Diluidas)$40.4M$45.5M$48.6M$49.5M$57.2M$62.3M$62.7M$62.7M$58.2M$63.5M

Cuenta de Resultados (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Ingresos00$9.9M$28.5M
Beneficio Bruto00$9.1M$27.7M
Beneficio Operativo-$26.4M-$29.1M-$17.4M$74000
EBITDA-$21.0M$82.1M$57.4M$17.6M
Beneficio Neto-$30.9M$86.5M$56.1M$13.2M
BPA$-0.47$1.42$0.78$0.18
BPA Diluido$-0.47$1.42$0.62$0.15

Balance (10 años)

Año2016201720182019202020212022202320242025
Caja y Equivalentes$2.2M$3.4M$5.9M$3.1M$10.5M$100.8M$11.0M$7.1M$3.4M$9.7M
Inversiones a Corto$43.1M$80.4M$54.6M$57.7M$124.5M$56.5M$183.9M$164.7M$86.7M$162.1M
Cuentas por Cobrar$12.0M$17.1M$22.8M$35.2M$3.8M$82.5M$242.0M$6.7M$36.8M$36.3M
Inventario$1.1M$443000$52.5M$1.1M$1.4M00000
Activos Corrientes$60.3M$108.4M$89.9M$103.7M$151.3M$248.0M$443.2M$217.9M$134.1M$215.7M
Inmovilizado Material$1.2M$2.1M$3.8M$30.9M$28.1M$30.0M$23.3M$20.6M$17.6M$12.5M
Fondo de Comercio0000000000
Activos Intangibles0000000000
Activos Totales$67.3M$116.3M$95.9M$137.0M$181.0M$419.3M$591.0M$378.3M$277.1M$325.6M
Cuentas por Pagar$2.5M$6.7M$6.3M$5.3M$4.2M$13.4M$6.0M$7.7M$5.9M$4.8M
Deuda a Corto000$3.5M00$94.4M$8.6M$21.0M$17.1M
Pasivos Corrientes$16.1M$26.3M$37.4M$55.5M$36.7M$51.8M$136.4M$53.3M$79.5M$78.1M
Deuda a Largo$79.5M$83.3M$149.0M$158.2M$236.3M$313.5M$220.9M$329.7M$166.6M$208.5M
Pasivos Totales$104.7M$119.1M-$4.2M$246.0M$301.8M$395.5M$505.3M$403.3M$459.7M$446.9M
Reservas-$469.9M-$523.4M$650.1M-$734.6M-$872.7M-$683.1M-$635.7M-$753.5M-$910.3M-$913.7M
Patrimonio Neto-$37.4M-$2.8M$650.1M-$109.0M-$120.8M$23.8M$85.7M-$25.0M-$182.6M-$121.2M
Deuda Total$80.0M$84.6M$151.4M$194.0M$268.8M$347.8M$342.0M$361.6M$207.0M$239.1M
Deuda Neta$34.7M$858000$91.0M$133.2M$133.9M$190.6M$147.1M$189.7M$116.9M$67.3M
Capital Circulante$44.2M$82.1M$52.5M$48.3M$114.5M$196.2M$306.9M$164.6M$54.6M$137.6M

Balance (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Caja y Equivalentes$2.4M$9.7M$1.9M$2.0M
Activos Totales$185.7M$325.6M$286.2M$286.8M
Pasivos Totales$406.2M$446.9M$349.5M$338.2M
Patrimonio Neto-$220.5M-$121.2M-$63.3M-$51.3M
Deuda Total$191.6M$239.1M$310.6M$83.8M

Flujo de Caja (10 años)

Año2016201720182019202020212022202320242025
Beneficio Neto-$66.7M-$53.5M-$126.8M-$84.5M-$138.1M-$191.5M-$182.0M-$117.8M-$156.8M-$3.4M
Amortizaciones$300000$551000$962000$1.8M$1.6M$1.4M$952000$920000$950000$964000
Compensación en Acciones$13.6M$12.7M$11.7M$13.8M$14.9M00$11.7M$10.5M$8.2M
Cambio en Capital Circulante-$6.2M-$172000$4.3M-$394000$7.6M-$14.1M-$119.0M$247.4M$29.7M$33.7M
Flujo de Caja Operativo-$51.5M-$36.2M-$103.7M-$60.1M-$100.1M-$109.7M-$86.5M$74.7M-$148.8M-$116.1M
Inversiones (CapEx)-$126000-$350000-$567000-$334000-$283000-$277000-$113000-$426000-$165000-$65000
Adquisiciones$12600000$30670$126.0M0000
Recompra de Acciones0000000-$4.7M-$11.9M0
Dividendos Pagados0000000000
Flujo de Caja Libre-$51.6M-$36.6M-$104.3M-$60.4M-$100.4M-$110.0M-$86.6M$74.3M-$149.0M-$116.2M

Flujo de Caja (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Flujo de Caja Operativo-$18.5M-$39.8M-$14.5M$4.1M
Inversiones (CapEx)-$1100000-$45000
Flujo de Caja Libre-$18.5M-$39.8M-$14.5M$4.1M
Dividendos Pagados0000
Compensación en Acciones$1.9M$1.7M0$1.6M

Crecimiento y Márgenes (10 años)

Año2016201720182019202020212022202320242025
Crecimiento Ingresos (anual)+55.8%-53.9%+274.3%-100.0%
Crecimiento Beneficio Neto (anual)+19.9%-137.0%+33.3%-63.4%+19.3%+142.6%-348.5%-33.1%+97.9%
Crecimiento BPA (anual)+29.1%-123.1%+17.2%-11.6%+25.7%+125.7%-508.7%-43.6%+98.0%
Cambio en Acciones (anual)+12.6%+6.7%+1.9%+15.5%+9.0%+0.6%+0.0%-7.3%+9.2%
Crecimiento FCF (anual)+29.2%-185.2%+42.1%-66.2%-9.6%+21.3%+185.8%-300.5%+22.0%
Margen Bruto96.6%98.3%98.3%97.6%
Margen Operativo-130.4%-67.7%-375.7%-56.7%
Margen EBITDA-140.9%-64.6%-410.0%-53.7%
Margen Neto-160.4%-82.5%-424.4%-75.6%
Margen FCF-124.1%-56.4%-349.2%-54.0%
Tasa Impositiva Efectiva-0.0%-0.0%9.3%-0.0%11.8%-0.0%-0.0%-0.0%-0.0%-72.0%

Datos por Acción (10 años)

Año2016201720182019202020212022202320242025
FCF por Acción$-1.28$-0.80$-2.15$-1.22$-1.76$-1.76$-1.38$1.18$-2.56$-1.83
Dividendo por Acción$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Acciones en Circulación (Básicas)$40.4M$45.5M$48.6M$49.5M$57.2M$62.3M$62.7M$62.7M$58.2M$63.5M

Qué mirar en Biotech

La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.

Rentabilidad

Rentabilidad sobre capital-109.40%
Rentabilidad sobre capital invertido-31.14%
Rentabilidad sobre activos43.52%
Margen bruto95.77%
Margen operativo-189.53%
Margen neto324.88%

Salud financiera

Deuda / Patrimonio-1.63
Ratio corriente1.95
Piotroski F-Score2
Altman Z-Score-3.20

Ratios Clave (10 años)

Año2016201720182019202020212022202320242025
P/E-6.01-16.61-4.27-6.52-5.93-3.594.91-1.74-3.66-326.00
P/VC-10.71-314.440.83-6.40-6.7716.861.65-8.21-3.15-9.00
P/V9.6413.6518.126.240.000.000.000.000.000.00
Margen Bruto96.6%98.3%98.3%97.6%0.0%0.0%0.0%0.0%0.0%0.0%
Margen Operativo-130.4%-67.7%-375.7%-56.7%0.0%0.0%0.0%0.0%0.0%0.0%
Margen Neto-160.4%-82.5%-424.4%-75.6%0.0%0.0%0.0%0.0%0.0%0.0%

Empresas relacionadas: ADCT · BCYC · FDMT · FULC · GOSS · KALV · LXRX

Explorar sector: Healthcare · Biotechnology

Más secciones de OMER: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos

Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones